June 8 (Reuters) – Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. (Reporting by Puyaan Singh in Bengaluru;
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Cadence unveils Nvidia-backed AI models that chipmakers can run in-house
By Stephen Nellis SAN FRANCISCO, Oct 26 (Reuters) - Cadence Design Systems on Monday launched…
Oil slips but stays near six-month highs on Saudi attacks
By Seher Dareen LONDON, Oct 26 (Reuters) - Oil prices fell on Monday after surging…
Kicky & Perky Begins New Growth Chapter with First Official Store and Expansion Plans
New Delhi [India], October 26: Contemporary fine jewellery brand Kicky & Perky has opened its…
